Genus plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genus plc with three other
miscellaneous service companies in Europe:
sales of 5.27 billion Swedish Kronor [US$621.35 million]
of which 61%
GW Pharmaceuticals PLC
(£407.91 million [US$567.34 million]
of which 100%
was Novel Therapeutics), and
based in BELGIUM
(530.26 million Euros [US$636.57 million]
During the year ended June of 2020, sales at
Genus plc were £551.40 million (US$766.90 million).
increase of 12.9%
versus 2019, when the company's sales were £488.50 million.
This was the fourth straight year of sales growth at Genus plc.
Sales of Operating Porcine Products Development saw an increase
24.5% in 2020, from
£9.40 million to £11.70 million.